This trial is testing whether giving the hormone CRH before a PET scan can help make pituitary gland tumors more visible.
1 Primary · 1 Secondary · Reporting Duration: Baseline
22 Total Participants · 1 Treatment Group
Primary Treatment: Acthrel · No Placebo Group · N/A
Age Any Age · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: